Biology and management of malignant pleural mesothelioma

This publication has 73 references indexed in Scilit:

• A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial
  Annals of Oncology, 2005
• Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
  Journal of Clinical Oncology, 2003
• The pathogenesis of mesothelioma
  Seminars in Oncology, 2002
• Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
  Oncogene, 2000
• Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma
  Journal of Cellular Physiology, 1999
• The European mesothelioma epidemic
  British Journal of Cancer, 1999
• Asbestos induces inflammatory cytokines in the lung through redox sensitive transcription factors
  Toxicology Letters, 1998
• Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation.
  American Journal of Respiratory Cell and Molecular Biology, 1996
• Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells.
  Proceedings of the National Academy of Sciences, 1995
• Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes
  Genes, Chromosomes and Cancer, 1989